In vivo cell reprogramming to pluripotency: exploring a novel tool for cell replenishment and tissue regeneration

被引:5
作者
de Lazaro, Irene [1 ,2 ]
Kostarelos, Kostas [1 ,2 ]
机构
[1] Univ Manchester, Fac Med & Human Sci, Nanomed Lab, Manchester M13 9PT, Lancs, England
[2] UCL, Fac Life Sci, UCL Sch Pharm, London WC1N 1AX, England
关键词
cell replacement; cell reprogramming; induced pluripotent stem cell (IPSC); pluripotency; EMBRYONIC STEM-CELLS; CAUDATE-NUCLEUS; THERAPY; TRANSPLANTATION; DISEASE; LIVER; ESTABLISHMENT; EXPRESSION; CHALLENGES; STRATEGIES;
D O I
10.1042/BST20140012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The potential of cell-replacement strategies for the treatment of disorders in which a particular cell type is damaged or degenerated has prompted the search for the perfect cell source. iPSCs (induced pluripotent stem cells) stand out as very advantageous candidates thanks to their self-renewal capacity and differentiation potential, together with the possibility of generating them from autologous somatic cells with minimally invasive techniques. However, their differentiation into the required cell type, precise delivery and successful engraftment and survival in the host are still challenging. We have proposed the transient reprogramming of somatic cells towards a pluripotent state in their in vivo microenvironment as a means to facilitate the regeneration of the tissue. The initial reports of in vivo reprogramming to pluripotency in the literature are reviewed and the potential clinical applications of this strategy are discussed.
引用
收藏
页码:711 / 716
页数:6
相关论文
共 55 条
  • [1] Reprogramming in vivo produces teratomas and iPS cells with totipotency features
    Abad, Maria
    Mosteiro, Lluc
    Pantoja, Cristina
    Canamero, Marta
    Rayon, Teresa
    Ors, Inmaculada
    Grana, Osvaldo
    Megias, Diego
    Dominguez, Orlando
    Martinez, Dolores
    Manzanares, Miguel
    Ortega, Sagrario
    Serrano, Manuel
    [J]. NATURE, 2013, 502 (7471) : 340 - +
  • [2] In vivo reprogramming of Sox9+ cells in the liver to insulin-secreting ducts
    Banga, Anannya
    Akinci, Ersin
    Greder, Lucas V.
    Dutton, James R.
    Slack, Jonathan M. W.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (38) : 15336 - 15341
  • [3] Induced pluripotent stem cells: the new patient?
    Bellin, Milena
    Marchetto, Maria C.
    Gage, Fred H.
    Mummery, Christine L.
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2012, 13 (11) : 713 - 726
  • [4] Repair or replace? Exploiting novel gene and cell therapy strategies for muscular dystrophies
    Benedetti, Sara
    Hoshiya, Hidetoshi
    Tedesco, Francesco Saverio
    [J]. FEBS JOURNAL, 2013, 280 (17) : 4263 - 4280
  • [5] Cell-Based Therapy for Neural Disorders - Anticipating Challenges
    Chiu, Arlene Y.
    Rao, Mahendra S.
    [J]. NEUROTHERAPEUTICS, 2011, 8 (04) : 744 - 752
  • [6] Chun YS, 2010, INT J BIOL SCI, V6, P796
  • [7] Japan punts on regenerative medicine
    Cyranoski, David
    [J]. NATURE BIOTECHNOLOGY, 2013, 31 (04) : 272 - 273
  • [8] Stem cells cruise to clinic
    Cyranoski, David
    [J]. NATURE, 2013, 494 (7438) : 413 - 413
  • [9] Japan's stimulus package showers science with cash
    Cyranoski, David
    [J]. NATURE, 2013, 493 (7433) : 465 - 465
  • [10] STEM CELLS Reprogramming in situ
    De Los Angeles, Alejandro
    Daley, George Q.
    [J]. NATURE, 2013, 502 (7471) : 309 - 310